Mangoceuticals (MGRX) Total Current Liabilities (2022 - 2026)

Mangoceuticals has disclosed Total Current Liabilities across 5 years of filings, most recently posting $737606.0 for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $737606.0, down 50.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $737606.0 (down 50.93% YoY), and the FY2025 annual result was $890568.0, down 37.52% from the prior year.
• Total Current Liabilities came in at $737606.0 for Q1 2026 at Mangoceuticals, down from $890568.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $159176.0 in Q3 2023.
• The 5-year median for Total Current Liabilities is $847421.5 (2025), against an average of $853861.2.
• Across the five-year window, Total Current Liabilities surged 774.12% in 2024 and sank 50.93% in 2026, its largest moves.
• Mangoceuticals' Total Current Liabilities stood at $260577.0 in 2022, then fell by 19.0% to $211078.0 in 2023, then soared by 575.33% to $1.4 million in 2024, then tumbled by 37.52% to $890568.0 in 2025, then retreated by 17.18% to $737606.0 in 2026.
• The last three Total Current Liabilities figures came in at $737606.0 (Q1 2026), $890568.0 (Q4 2025), and $804275.0 (Q3 2025), per Business Quant data.